IRD vs VRTX: Which Stock is Better?
Side-by-side comparison of Opus Genetics Inc and Vertex Pharmaceuticals Inc in 2026
IRD
Opus Genetics Inc
$5.75
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | IRD | VRTX | Winner |
|---|---|---|---|
| Market Cap | $409.11M | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | -0.1% | 0.1% | VRTX |
| Gross Margin | -117.0% | 53.7% | VRTX |
Analyze IRD
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRD or VRTX a better investment?
Comparing IRD and VRTX: Opus Genetics Inc has a market cap of $409.11M while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRD and VRTX?
IRD (Opus Genetics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRD or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRD or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.1% for IRD.
Which company is more profitable: IRD or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -117.0% for IRD.
Which is the larger company: IRD or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $409.11M for IRD.
Should I buy IRD or VRTX in 2026?
Both IRD and VRTX have investment merit. IRD trades at $5.75 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRD and VRTX stock?
Key differences: Market Cap ($409.11M vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (-117.0% vs 53.7%).